Logo image of MUX

MCEWEN INC (MUX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MUX - US58039P3055 - Common Stock

17.86 USD
+0.37 (+2.12%)
Last: 11/26/2025, 8:04:00 PM
18 USD
+0.14 (+0.78%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

3

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 153 industry peers in the Metals & Mining industry. Both the profitability and financial health of MUX have multiple concerns. MUX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MUX had negative earnings in the past year.
MUX had a positive operating cash flow in the past year.
In the past 5 years MUX reported 4 times negative net income.
In the past 5 years MUX reported 4 times negative operating cash flow.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

MUX has a Return On Assets of -1.59%. This is comparable to the rest of the industry: MUX outperforms 49.67% of its industry peers.
MUX has a Return On Equity of -2.44%. This is comparable to the rest of the industry: MUX outperforms 49.67% of its industry peers.
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 18.34%, MUX is in line with its industry, outperforming 55.56% of the companies in the same industry.
MUX's Gross Margin has improved in the last couple of years.
MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MUX has been increased compared to 1 year ago.
MUX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MUX has an improved debt to assets ratio.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.00, we must say that MUX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MUX (0.00) is worse than 87.58% of its industry peers.
MUX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
MUX has a worse Debt to Equity ratio (0.26) than 62.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACC8.64%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.10 indicates that MUX has no problem at all paying its short term obligations.
MUX's Current ratio of 2.10 is in line compared to the rest of the industry. MUX outperforms 41.18% of its industry peers.
MUX has a Quick Ratio of 1.58. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
MUX's Quick ratio of 1.58 is in line compared to the rest of the industry. MUX outperforms 51.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.58
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.80% over the past year.
Looking at the last year, MUX shows a very negative growth in Revenue. The Revenue has decreased by -16.62% in the last year.
Measured over the past years, MUX shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%

3.2 Future

MUX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 113.90% yearly.
The Revenue is expected to grow by 11.41% on average over the next years. This is quite good.
EPS Next Y165.49%
EPS Next 2Y112.91%
EPS Next 3Y113.9%
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y9.35%
Revenue Next 3Y11.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 11.37, the valuation of MUX can be described as reasonable.
Based on the Price/Forward Earnings ratio, MUX is valued a bit cheaper than 76.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, MUX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 11.37
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

MUX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 82.87
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MUX's earnings are expected to grow with 113.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.91%
EPS Next 3Y113.9%

0

5. Dividend

5.1 Amount

No dividends for MUX!.
Industry RankSector Rank
Dividend Yield N/A

MCEWEN INC

NYSE:MUX (11/26/2025, 8:04:00 PM)

After market: 18 +0.14 (+0.78%)

17.86

+0.37 (+2.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners43.82%
Inst Owner Change2.64%
Ins Owners0.55%
Ins Owner Change0.82%
Market Cap972.66M
Revenue(TTM)166.45M
Net Income(TTM)-11.92M
Analysts80
Price Target23.66 (32.47%)
Short Float %17.16%
Short Ratio4.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)193.94%
Min EPS beat(2)-106.19%
Max EPS beat(2)494.06%
EPS beat(4)1
Avg EPS beat(4)46.88%
Min EPS beat(4)-197.03%
Max EPS beat(4)494.06%
EPS beat(8)3
Avg EPS beat(8)8.28%
EPS beat(12)5
Avg EPS beat(12)-40.66%
EPS beat(16)6
Avg EPS beat(16)-62.37%
Revenue beat(2)0
Avg Revenue beat(2)-13.91%
Min Revenue beat(2)-22.09%
Max Revenue beat(2)-5.74%
Revenue beat(4)1
Avg Revenue beat(4)-8.56%
Min Revenue beat(4)-22.09%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)-3.06%
Revenue beat(16)6
Avg Revenue beat(16)-5.73%
PT rev (1m)49.68%
PT rev (3m)51.51%
EPS NQ rev (1m)-36.07%
EPS NQ rev (3m)56%
EPS NY rev (1m)60.8%
EPS NY rev (3m)228.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.57%
Revenue NY rev (1m)7.08%
Revenue NY rev (3m)14.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.37
P/S 5.84
P/FCF N/A
P/OCF 381.58
P/B 1.99
P/tB 1.99
EV/EBITDA 82.87
EPS(TTM)-0.34
EYN/A
EPS(NY)1.57
Fwd EY8.79%
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)0.05
OCFY0.26%
SpS3.06
BVpS8.97
TBVpS8.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.34%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 10.66
Cap/Depr 181.37%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 21.58%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.58
Altman-Z 0
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y165.49%
EPS Next 2Y112.91%
EPS Next 3Y113.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%
Revenue Next Year-3.04%
Revenue Next 2Y9.35%
Revenue Next 3Y11.41%
Revenue Next 5YN/A
EBIT growth 1Y-1953.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3Y101.59%
EBIT Next 5YN/A
FCF growth 1Y57.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.9%
OCF growth 3YN/A
OCF growth 5YN/A

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MUX.


Can you provide the valuation status for MCEWEN INC?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX). This can be considered as Fairly Valued.


What is the profitability of MUX stock?

MCEWEN INC (MUX) has a profitability rating of 2 / 10.


What is the financial health of MCEWEN INC (MUX) stock?

The financial health rating of MCEWEN INC (MUX) is 3 / 10.